Variant report

Variant	nsv1033952
Chromosome Location	chr8:8108863-8169587
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:85)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:85 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr8:8147966..8148515-chr8:8336160..8336710,2	MCF-7	breast:
2	chr8:8151935..8153565-chr8:8167280..8169778,2	MCF-7	breast:
3	chr8:8146386..8147240-chr8:8365579..8366086,2	MCF-7	breast:
4	chr8:8142616..8145069-chr8:8226333..8228141,2	MCF-7	breast:
5	chr8:8146657..8147172-chr8:8172119..8172832,2	MCF-7	breast:
6	chr8:8130411..8130935-chr8:8374466..8375028,2	K562	blood:
7	chr8:8148672..8150547-chr8:8158525..8160965,2	MCF-7	breast:
8	chr8:8138288..8140321-chr8:8142532..8144155,2	MCF-7	breast:
9	chr8:8151768..8153956-chr8:8305542..8308270,3	MCF-7	breast:
10	chr8:8152575..8156744-chr8:8165539..8169727,4	MCF-7	breast:
11	chr8:8146134..8147870-chr8:8228066..8231062,2	MCF-7	breast:
12	chr8:8151537..8155554-chr8:8160869..8164322,5	MCF-7	breast:
13	chr8:8134812..8136654-chr8:8146118..8147961,3	K562	blood:
14	chr8:8147508..8148471-chr8:8365206..8366162,5	MCF-7	breast:
15	chr8:8138288..8140321-chr8:8142532..8144155,2	MCF-7	breast:
16	chr8:8145815..8148362-chr8:8152420..8155525,4	MCF-7	breast:
17	chr8:8146402..8147201-chr8:8172122..8172875,3	MCF-7	breast:
18	chr8:8128833..8131355-chr8:8136442..8139093,2	MCF-7	breast:
19	chr8:8140760..8143388-chr8:8146728..8148425,2	K562	blood:
20	chr8:8146302..8147264-chr8:8365295..8366108,2	MCF-7	breast:
21	chr8:8130384..8131365-chr8:8526780..8528280,9	K562	blood:
22	chr8:8126556..8131624-chr8:8143035..8148399,10	MCF-7	breast:
23	chr8:8145815..8148362-chr8:8152420..8155525,4	MCF-7	breast:
24	chr8:8130322..8131342-chr8:8527334..8528198,3	MCF-7	breast:
25	chr8:8145045..8147805-chr8:8168275..8170393,2	MCF-7	breast:
26	chr5:40835342..40835901-chr8:8146133..8146693,2	Hela-S3	cervix:
27	chr8:8131655..8133179-chr8:8135431..8137292,2	MCF-7	breast:
28	chr8:8147577..8148479-chr8:8171987..8172936,6	MCF-7	breast:
29	chr8:8131655..8133179-chr8:8135431..8137292,2	MCF-7	breast:
30	chr8:8145925..8147772-chr8:8172599..8174671,2	MCF-7	breast:
31	chr8:8154932..8157234-chrX:48930489..48933092,2	MCF-7	breast:
32	chr8:8144670..8146200-chr8:8236707..8239376,2	MCF-7	breast:
33	chr8:8155614..8158517-chr8:8163567..8165783,2	MCF-7	breast:
34	chr8:8155614..8158517-chr8:8163567..8165783,2	MCF-7	breast:
35	chr8:8142878..8144520-chr8:8146399..8149197,2	MCF-7	breast:
36	chr8:8130511..8132438-chr8:8135661..8137544,2	K562	blood:
37	chr8:8163385..8165177-chr8:8167014..8169330,2	MCF-7	breast:
38	chr8:8146324..8147133-chr8:8168152..8168656,2	MCF-7	breast:
39	chr8:8094104..8095024-chr8:8146401..8147333,3	MCF-7	breast:
40	chr8:8134812..8136654-chr8:8146118..8147961,3	K562	blood:
41	chr8:8147577..8148485-chr8:8171987..8172936,5	MCF-7	breast:
42	chr8:8128833..8131355-chr8:8136442..8139093,2	MCF-7	breast:
43	chr8:8108549..8111183-chr8:8240516..8242778,2	MCF-7	breast:
44	chr8:8147727..8148466-chr8:8172098..8172982,3	MCF-7	breast:
45	chr8:8168175..8169902-chr8:8242938..8245869,2	MCF-7	breast:
46	chr8:8118434..8122893-chr8:8123384..8125953,5	MCF-7	breast:
47	chr8:8147573..8150272-chr8:8166843..8168780,2	MCF-7	breast:
48	chr8:8151372..8154142-chr8:8175847..8177840,2	MCF-7	breast:
49	chr8:8094104..8094693-chr8:8146401..8147333,2	MCF-7	breast:
50	chr8:8134161..8136694-chr8:8559309..8560894,2	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PRAGMIN.1-6	chr8:8150269-8151573	NONHSAT124869
2	lnc-PRAGMIN.1-6	chr8:8151715-8152356	NONHSAT124869

No data

Variant related genes	Relation type
ENSG00000243279	chromatin interactions
ENSG00000105281	chromatin interactions
ENSG00000145592	chromatin interactions
ENSG00000173295	chromatin interactions
ENSG00000176305	chromatin interactions
ENSG00000253958	chromatin interactions
ENSG00000254153	chromatin interactions
ENSG00000253981	chromatin interactions
ENSG00000182319	chromatin interactions
ENSG00000196998	chromatin interactions

Extended variants
information (count: 3383 )
Associated
traits (count: 145 )

Variant overlapped rSNPs/rCNVs (count:3383 , 50 per page) page: 1 2 3 4 5 6 7 ... 68

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs367612541	chr8:8108915-8108916	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs569022537	chr8:8108947-8108948	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs537833096	chr8:8108993-8108994	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs184860555	chr8:8109030-8109031	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs574988237	chr8:8109033-8109034	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs189236650	chr8:8109034-8109035	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs149297984	chr8:8109054-8109055	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs564337072	chr8:8109055-8109056	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs76964238	chr8:8109057-8109058	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs562639415	chr8:8109082-8109083	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs114348417	chr8:8109129-8109130	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs144525554	chr8:8109143-8109144	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs180966935	chr8:8109194-8109195	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs573912643	chr8:8109245-8109246	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs6997838	chr8:8109255-8109256	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs546885683	chr8:8109308-8109309	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs562645879	chr8:8109337-8109338	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs549578498	chr8:8109349-8109350	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs532347042	chr8:8109362-8109363	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs6982641	chr8:8109368-8109369	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs568934182	chr8:8109406-8109407	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs139653350	chr8:8109409-8109410	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs547849397	chr8:8109432-8109433	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs568064078	chr8:8109433-8109434	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs185139057	chr8:8109462-8109463	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs554022424	chr8:8109467-8109468	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs35205846	chr8:8109479-8109480	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs577163451	chr8:8109533-8109534	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs545423672	chr8:8109540-8109541	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs539635368	chr8:8109541-8109542	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs145180654	chr8:8109557-8109558	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs576079409	chr8:8109578-8109579	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs565119043	chr8:8109585-8109586	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs190672094	chr8:8109605-8109606	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs561896715	chr8:8109666-8109667	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs572387695	chr8:8109674-8109675	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs181475373	chr8:8109701-8109702	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs186211877	chr8:8109716-8109717	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs386721940	chr8:8109718-8109719	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs533285523	chr8:8109757-8109758	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs546935918	chr8:8109833-8109834	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs192013996	chr8:8109877-8109878	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs532459468	chr8:8109897-8109898	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs545976679	chr8:8109904-8109905	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs2945230	chr8:8109936-8109937	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
46	rs531275514	chr8:8110009-8110010	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs548252748	chr8:8110102-8110103	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs568091468	chr8:8110105-8110106	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs527275716	chr8:8110117-8110118	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs547030096	chr8:8110183-8110184	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:145)

Disease	PMID	Source
abnormal development	18461090	CNVD
Crohn''s disease	19220326	CNVD
Psoriasis	19220326	CNVD
Prostate cancer	21965145	CNVD
Prostate cancer	18515986	CNVD
Chronic obstructive pulmonary disease	20378733	CNVD
Autism	18414403	CNVD
Cancer	21183584	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	17603634	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Ovarian cancer	20844748	CNVD
Cervical cancer	17311676	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Schizophrenia	20877625	CNVD
Disorders of sex development	21048976	CNVD
Colorectal cancer	16272173	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	17001317	CNVD
Thyroid cancer	19087340	CNVD
Multiple myeloma	16616336	CNVD
Hepatocellular carcinoma	22174799	CNVD
Heart disease	21282601	CNVD
Prostate cancer	16573809	CNVD
T-cell lymphomas	19863542	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	21297112	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Breast cancer	17393978	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Breast cancer	21785460	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21509527	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Congenital diaphragmatic hernia	21064195	CNVD
Autism	22495311	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Breast cancer	16608533	CNVD
Seminomas	18059402	CNVD
Lung cancer	18438408	CNVD
Colorectal cancer	16774939	CNVD
Lung squamous cell carcinoma	22363434	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Breast cancer	21990379	CNVD
Psoriasis	20403174	CNVD
Psoriasis	20663923	CNVD
Crohn''s disease	16909382	CNVD
Cancer	21129771	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Crohn''s disease	20877625	CNVD
Inflammatory disorder	20877625	CNVD
Cardiac defect	21933911	CNVD
Psoriasis	18059266	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Psoriasis	20877625	CNVD
Mental retardation	17847001	CNVD
Prostate cancer	17217626	CNVD
Schizophrenia	21399695	CNVD
Colorectal cancer	21128281	CNVD
Colorectal cancer	19455253	CNVD
Psoriasis	18848619	CNVD
Squamous cell cancer	19047905	CNVD
Colorectal cancer	17229543	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Bladder cancer	21909424	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
small cell lung cancer	20016488	CNVD
Incontinentia Pigmenti	22033527	CNVD
Williams Syndrome	20824207	CNVD
Urothelial carcinoma	21177765	CNVD
Myxofibrosarcoma	16751306	CNVD
Immune disease	21572526	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Kallmann Syndrome 2	22470819	CNVD
Developmental disorder	20461109	CNVD
early-passage human iPS cells	21368824	CNVD
Schizophrenia	21346763	CNVD
Schizophrenia	20967226	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	22522925	CNVD
Cancer	20164919	CNVD
Glioblastoma multiforme	21138945	CNVD
Breast cancer	21364760	CNVD

Chromatin state (count:1196 , 50 per page) page: 1 2 3 4 5 6 7 ... 24

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:8102400-8111400	Weak transcription	Fetal Intestine Small	intestine
2	chr8:8106200-8113200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr8:8108200-8111200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
4	chr8:8108400-8109000	Enhancers	Sigmoid Colon	Sigmoid Colon
5	chr8:8108400-8109200	Enhancers	Breast Myoepithelial Primary Cells	Breast
6	chr8:8108400-8109200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
7	chr8:8108400-8109200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
8	chr8:8108400-8109200	Enhancers	Fetal Intestine Large	intestine
9	chr8:8108400-8109200	Enhancers	Fetal Kidney	kidney
10	chr8:8108400-8109400	Enhancers	A549	lung
11	chr8:8108400-8109600	Enhancers	HMEC	breast
12	chr8:8108400-8109600	Enhancers	NHEK	skin
13	chr8:8108400-8110000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
14	chr8:8108400-8110400	Enhancers	Rectal Mucosa Donor 31	rectum
15	chr8:8108400-8110600	Enhancers	Hela-S3	cervix
16	chr8:8108400-8111000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
17	chr8:8108400-8111600	Enhancers	HepG2	liver
18	chr8:8108600-8109600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
19	chr8:8108600-8109600	Flanking Active TSS	HUVEC	blood vessel
20	chr8:8108600-8109800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
21	chr8:8108600-8109800	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
22	chr8:8108600-8109800	Enhancers	Fetal Lung	lung
23	chr8:8108600-8110400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
24	chr8:8108800-8109200	Enhancers	Rectal Mucosa Donor 29	rectum
25	chr8:8108800-8109200	Enhancers	HSMM	muscle
26	chr8:8108800-8109200	Bivalent Enhancer	Osteobl	bone
27	chr8:8108800-8110000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
28	chr8:8108800-8110200	Weak transcription	Placenta Amnion	Placenta Amnion
29	chr8:8109000-8109400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
30	chr8:8109000-8109600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
31	chr8:8109200-8110800	Weak transcription	Fetal Kidney	kidney
32	chr8:8109200-8111800	Weak transcription	Fetal Intestine Large	intestine
33	chr8:8109200-8113000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
34	chr8:8109200-8113000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
35	chr8:8109600-8110600	Enhancers	HUVEC	blood vessel
36	chr8:8109600-8112200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
37	chr8:8109600-8112800	Weak transcription	NHEK	skin
38	chr8:8109600-8113000	Weak transcription	HMEC	breast
39	chr8:8109800-8110000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
40	chr8:8109800-8110400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
41	chr8:8109800-8119800	Weak transcription	Fetal Lung	lung
42	chr8:8110000-8112200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
43	chr8:8110200-8112800	Enhancers	Placenta Amnion	Placenta Amnion
44	chr8:8110400-8111400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
45	chr8:8110400-8111600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
46	chr8:8110600-8115000	Weak transcription	Hela-S3	cervix
47	chr8:8110800-8111200	Enhancers	Fetal Kidney	kidney
48	chr8:8111400-8112000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
49	chr8:8111400-8112200	Enhancers	Liver	Liver
50	chr8:8111400-8112400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links